Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 90,000 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $13.42, for a total value of $1,207,800.00. Following the transaction, the chief executive officer now directly owns 2,453,100 shares in the company, valued at approximately $32,920,602. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC opened at $12.78 on Thursday. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market capitalization of $2.45 billion, a price-to-earnings ratio of -16.60 and a beta of 1.45. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $14.25. The business has a 50 day simple moving average of $11.49 and a 200-day simple moving average of $9.28.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) earnings per share for the quarter, hitting the consensus estimate of ($0.14). The firm had revenue of $692.43 million for the quarter, compared to analyst estimates of $662.11 million. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. Alignment Healthcare’s quarterly revenue was up 51.6% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.19) earnings per share. As a group, equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

ALHC has been the subject of a number of research reports. TD Cowen boosted their price objective on Alignment Healthcare from $8.00 to $10.00 and gave the company a “buy” rating in a research note on Tuesday, August 6th. UBS Group increased their target price on Alignment Healthcare from $9.00 to $12.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 30th. Barclays upped their price target on Alignment Healthcare from $7.00 to $8.00 and gave the stock an “underweight” rating in a report on Wednesday, October 30th. Robert W. Baird upped their price target on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an “outperform” rating in a report on Wednesday, August 14th. Finally, Piper Sandler restated an “overweight” rating and set a $10.00 price objective (up previously from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $10.33.

Hedge Funds Weigh In On Alignment Healthcare

Several institutional investors have recently modified their holdings of ALHC. Virtu Financial LLC acquired a new position in shares of Alignment Healthcare during the first quarter valued at $57,000. nVerses Capital LLC bought a new position in shares of Alignment Healthcare in the third quarter valued at approximately $95,000. Principal Financial Group Inc. increased its stake in shares of Alignment Healthcare by 18.1% during the second quarter. Principal Financial Group Inc. now owns 13,521 shares of the company’s stock valued at $106,000 after acquiring an additional 2,077 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Alignment Healthcare during the third quarter worth approximately $131,000. Finally, Creative Planning lifted its position in Alignment Healthcare by 20.0% in the third quarter. Creative Planning now owns 12,442 shares of the company’s stock worth $147,000 after purchasing an additional 2,072 shares during the period. Institutional investors own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.